This was the first paper reported the structure of the SARS-CoV-2 spike 
protein. 
9. Barnes CO, et al.: SARS-CoV-2 neutralizing antibody structures 
inform therapeutic strategies. Nature 2020, 588:682-687. 
10. Liu C, et al.: The antibody response to SARS-CoV-2 Beta 
underscores the antigenic distance to other variants. Cell Host 
Microbe 2022, 30:e12. 
11.
••
Nutalai R, et al.: Potent cross-reactive antibodies following 
Omicron breakthrough in vaccinees". Cell 2022, 185:2116-2131. 
A potent broadly neutralizing mAb (Omi-42) against all previously and 
currently circulating SARS-CoV-2 strains was reported in this paper. 
12. Hastie KM, et al.: Defining variant-resistant epitopes targeted by 
SARS-CoV-2 antibodies: a global consortium study. Science 
2021, 374:472-478. 
13. Wang P, et al.: Antibody resistance of SARS-CoV-2 variants B. 
1.351 and B.1.1.7. Nature 2021, 593:130-135. 
14. Graham C, et al.: Neutralization potency of monoclonal